Organization | National Institute of Health Research and Development, Jakarta, Indonesia

National Institute of Health Research and Development, Jakarta, Indonesia Report issue

Government Phase 3

Founded: Jakarta Indonesia (2015)

Organization Overview

First Clinical Trial

None

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2008

Timeline

NOW

Now

Alternative names

National Institute of Health Research and Development (NIHRD), Indonesia

Active Ingredients

Drugs in Phase 3 Trials (2)

arginine (2 trials)

vitamin d3 (1 trial)

Drugs in Other Trials (9)

amodiaquine (camoquin) (1 trial)

artesunate (1 trial)

chloroquine (1 trial)

coartemether (1 trial)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 6
# of Trial APIs: 11